PROF. DR. SEE MEE HOONG
Department of Surgery
Faculty of Medicine
smhoong76um.edu.myView CV | |
View 1-Page CV | |
Personal Homepage | |
Publons | |
Scopus Link | |
PubMed Link | |
Biography | |
Professor Dr. See Mee-Hoong Professor Dr. See Mee-Hoong is an esteemed senior lecturer at the University of Malaya and a dedicated Consultant Oncoplastic Breast Surgeon at the University Malaya Medical Center (UMMC). Graduating with her undergraduate medical degree from UPM in 2003, she continued her academic excellence by earning her Master's Degree in Surgery (General Surgery) from the University of Malaya in May 2011 and obtained her fellowship in Breast Oncoplastic training from 2012 to 2015 in Universiti Malaya and Mahidol University, Thailand. Currently, she is nationally registered as a Breast Oncoplastic Surgeon. Her commitment to medical education and clinical practice led her to join the University Malaya Medical Faculty in 2012, where she specialized as a clinical lecturer focusing on Breast Oncoplastic Surgery. Dr. See further honed her skills as an honorary fellow at Siriraj Hospital, Mahidol University, Bangkok, Thailand in 2013, and later completed advanced training in minimally invasive techniques and Cryoablation at Kameda Medical Centre under Dr. Eisuke Fukuma in 2016. In 2022, Dr. See underwent robotic breast surgery training at Chang Hua Christian Medical Centre, Taichung, Taiwan. She has since pioneered minimally invasive breast surgeries at UMMC, offering patients the benefits of early recovery, smaller scars, better aesthetic outcomes, and comparable oncological results. A pioneer in Malaysia, she introduced 2D and 3D endoscopic nipple-sparing mastectomy (NSM) as early as 2019 and pioneer the FIRST MALAYSIA Robotic NSM with immediate implant reconstruction in 2025 . She has also been elected as a council member of Breast Surgical International in 2024, marking significant milestones in her leadership and expertise. Dr. See serves as the clinical head of the Breast Surgery Unit at UMMC (currently known as the Breast and Endocrine Unit), where she leads a team committed to providing high-quality care to patients. Her research interests span Clinical Breast Surgical Oncology, including Oncoplastic Surgery, Minimally Invasive and Robotic Breast Surgery, Enhanced Recovery After Surgery (ERAS), and Intraoperative Radiotherapy (IORT). She has published over 70 scientific papers, led the development of Decision Aids in Breast Reconstruction, and is actively involved in multiple clinical trials, including the TARGIT-B trial. Dr. See is also actively engaged in advancing artificial intelligence (AI) in breast cancer diagnosis. She is currently collaborating with Kyungpook National University, Daegu, South Korea, on a clinical trial exploring AI applications for breast cancer diagnostics and treatment planning. A driving force in Dr. See's work is her passion for uniting Southeast Asian and Asian breast surgeons through knowledge sharing and collaboration. She spearheads this effort through the Asian Breast Surgery Forum (ABSF – an ECHO Project), which she leads in collaboration with the University of New Mexico’s Project ECHO®. The forum connects 12 Asian countries, fostering the exchange of expertise and best practices in breast surgery. Dr. See is actively involved in various international surgical organizations, including the International Oncoplastic Breast Surgery (IOPBS) and the International Endoscopic and Robotic Breast Surgery (IERBS) societies, contributing to the global advancement of breast surgical practices. Currently, Dr. See serves as the Deputy Head of the Visibility Unit in the Faculty of Medicine at the University of Malaya. Her leadership and vision continue to impact the field of breast surgery, both regionally and globally, as she remains dedicated to enhancing surgical standards, research, and patient outcomes. |
Publication
Finance
Project Title | Progress | Status |
---|---|---|
The Development Of Artificial Intelligence-based Techniques In Precision Surgical Planning For Breast Reconstruction |
|
end |
An In-vivo Optical Fibre Radiation Dosimetry System For The Intrabeamic System In Breast Cancer Patients Undergoing Breast Conserving Surgery Intraoperative Radiotheraphy |
|
end |
Determinants Of Adherence To Therapies Among Malaysian Women With Breast Cancer: Mybcc Cohort |
|
end |
This information is generated from Research Grant Management System |
Patients’ Acceptability and Perspective on Utilizing Telemedicine in Breast Cancer Care and Management
Efficacy of Flat-Silicone Versus Round-Silicone Perforated Drains in Seroma Formation and Other Outcomes Following Mastectomy: A Single-Blinded Randomized Controlled Trial
Transforming care: Optimizing ERAS pathway in breast cancer surgery with latissimus dorsi flap
Age-specific breast and ovarian cancer risks associated with germline BRCA1 or BRCA2 pathogenic variants – an Asian study of 572 families
PINK AGENT : STORIES FROM PATIENTS
Pink Agent